2025 -  WEEK 14

What's New in RWE Research this Week

 

  1. Overall survival of palbociclib plus endocrine therapy in Japanese patients with HR+/HER2- advanced breast cancer in the first-or second-line setting: a multicenter observational study (P-BRIDGE study). Nagai SE, Hattori M, Yoshinami T, Masuda H, Okamura T, Watanabe K, Nakayama T, Tsuneizumi M, Takabatake D, Harao M, Yoshino H, Mori N, Yasojima H, Oshiro C, Iwase M, Yamaguchi M, Sangai T, Sasada S, Ishida T, Futamura M, Muramatsu Y, Kosaka N, Masuda N.Breast Cancer. 2025 Apr 5. doi: 10.1007/s12282-025-01689-4. Online ahead of print.PMID: 40186791

 

  1. Risk of fungal infection in psoriasis patients treated with IL-17 and IL-23 inhibitors: a multi-cohort study using real-world data. Islam RK, Maltese A, Lipner SR.Arch Dermatol Res. 2025 Apr 5;317(1):678. doi: 10.1007/s00403-025-04188-w.PMID: 40186761 No abstract available.

 

  1. Effectiveness of drugs employed in the treatment of COVID-19: real-world evidence. Quintana JM, Larrea N, Menéndez L, Legarreta MJ, Gascon M, Garcia-Asensio J, España PP; COVID-Health Basque Country Research Group.Expert Rev Respir Med. 2025 Apr 5. doi: 10.1080/17476348.2025.2488966. Online ahead of print.PMID: 40186558

 

  1. Public engagement with science: an inclusive approach to innovate in health research with real-world data. Dos Anjos Fonseca A, Martufi V, de Araújo WA, Pimenta DM, de Lima AMP, de Faria JAP, Dias DLC, Dos Anjos EF, Flores Quispe MDP, Piloto GR, Lima VMQ, Ferré F, Sampaio MAGA, de Souza Lopes E, de Mello BH, Daltro DCT, de Almeida MRS, Lima RT, Pinto Junior EP, Barreto ML, Ichihara MYT.BMC Med Res Methodol. 2025 Apr 4;25(1):88. doi: 10.1186/s12874-025-02530-4.PMID: 40186142

 

  1. Development and validation of a clinical prognosis prediction model for malignant intestinal obstruction: A retrospective cohort study. Duan H, Tao R, Qin J.Sci Rep. 2025 Apr 4;15(1):11550. doi: 10.1038/s41598-025-96593-4.PMID: 40185941

 

  1. Does BMI matter when treating depression with esketamine? A retrospective analysis of real-world data. Ansari M, Rhee TG, Santucci MC, Nikayin S.J Affect Disord. 2025 Apr 2:S0165-0327(25)00548-8. doi: 10.1016/j.jad.2025.03.198. Online ahead of print.PMID: 40185405

 

  1. Using Real-World Data for Machine-Learning Algorithms to Predict the Treatment Response in Advanced Melanoma: A Pilot Study for Personalizing Cancer Care. Brohet RM, de Boer ECS, Mossink JM, van der Eerden JJN, Oostmeyer A, Idzerda LHW, Maring JG, Paardekooper GMRM, Beld M, Lijffijt F, Dille J, de Groot JWB.JCO Clin Cancer Inform. 2025 Apr;9:e2400181. doi: 10.1200/CCI-24-00181. Epub 2025 Apr 4.PMID: 40184559

 

  1. Real-world avelumab first-line maintenance in advanced urothelial carcinoma: systematic review and meta-analysis. Barthélémy P, Musat MG, Moradian H, Kearney M.Future Oncol. 2025 Apr 4:1-12. doi: 10.1080/14796694.2025.2475734. Online ahead of print.PMID: 40184226 Review.

 

  1. Clinical whole genome sequencing in pediatric epilepsy: Genetic and phenotypic spectrum of 733 individuals. Henry OJ, Ygberg S, Barbaro M, Lesko N, Karlsson L, Peña-Pérez L, Båvner A, Töhönen V, Lindstrand A, Stödberg T, Wedell A. 2025 Apr 4. doi: 10.1111/epi.18403. Online ahead of print.PMID: 40183601

 

  1. Real-world evidence of riluzole on survival and ALSFRS change in a Chinese ALS cohort. Jiang J, Li X, Mi Y, Wang Y, Heng Y, Li Z, Deng M.Neurodegener Dis Manag. 2025 Apr 4:1-11. doi: 10.1080/17582024.2025.2488235. Online ahead of print.PMID: 40183433

 

  1. Heterogeneous effects of obesity on all-cause mortality: A causal forest analysis of hospitalized patients in China. Liu M, Xu Z, He L, Xu X, Cai X, Guo Y, Zhang S, Xu X, Xiong Z, Zhuang X, Liao X.Diabetes Obes Metab. 2025 Apr 4. doi: 10.1111/dom.16391. Online ahead of print.PMID: 40183390

 

  1. Real-world data of immune-related adverse events in lung cancer patients receiving immune-checkpoint inhibitors. Hu X, Rodday AM, Gurinovich A, Pan S, Salei YV, Lin JH, Byrne MM, Cao Y, Pai L, Parsons SK. 2025 Apr 4:1-9. doi: 10.1080/1750743X.2025.2488728. Online ahead of print.PMID: 40183219

 

  1. Real-world use of antispasmodic drugs during IUD insertion - insights from the large observational study EURAS-LCS12. Eggebrecht L, Rizzo M, Klinghardt M, Böhnke T, Barnett C, Heinemann K.Eur J Contracept Reprod Health Care. 2025 Apr 4:1-4. doi: 10.1080/13625187.2025.2480086. Online ahead of print.PMID: 40183207

 

  1. Evaluation of Long-Term Effects of Parathyroidectomy in Patients With Refractory Secondary Hyperparathyroidism. Yang L, Zhang NR, Wang HF, Chen JN, Yang M, Sun XL, Lv Y, Lu Y, Jia WN, He WW, Zhang L.Hemodial Int. 2025 Apr 4. doi: 10.1111/hdi.13222. Online ahead of print.PMID: 40183161

 

  1. Real-world outcomes of lenvatinib plus pembrolizumab in intermediate- and poor-risk metastatic renal cell carcinoma. Tsimafeyeu I, Sultanbaev A, Dubovichenko D, Murzalina M, Volkov A, Orlova R, Utyashev I, Malina G, Gluzman M.Explor Target Antitumor Ther. 2025 Apr 1;6:1002305. doi: 10.37349/etat.2025.1002305. eCollection 2025.PMID: 40182649 Free PMC article.

 

  1. Association of tirzepatide with glycaemic control and weight loss in a real world cohort of patients with type 2 diabetes from the United States. Mody R, Desai K, Teng CC, Reznor G, Stockbower G, Grabner M, Benneyworth BD.Diabetes Obes Metab. 2025 Apr 4. doi: 10.1111/dom.16372. Online ahead of print.PMID: 40181696

 

  1. A retrospective research of adverse event reporting system events for voxelotor based on the FAERS database. Lin Y, Li H, Dong Y, Fang W, Huang H, He M, Zhou X, Sun N.BMC Pharmacol Toxicol. 2025 Apr 3;26(1):74. doi: 10.1186/s40360-025-00915-1.PMID: 40181444 Free PMC article.

 

  1. The association between objectively measured physical activity and home blood pressure: a population-based real-world data Kinuta M, Hisamatsu T, Taniguchi K, Fukuda M, Nakahata N, Kanda H.J Hum Hypertens. 2025 Apr 3. doi: 10.1038/s41371-025-01014-8. Online ahead of print.PMID: 40181092

 

  1. OrPhar-SEFH 2024-2027 Strategic Plan. Climente Martí M, Edo Solsona MD, Abad Sazatornil MR, Bachiller Cacho MP, Fernández Espinola S, Guijarro Martínez P, Gras Colomer E, Herrero Ambrosio A, Manrique Rodríguez S, Martín Herranz I, Martínez Sesmero JM, Poveda Andrés JL.Farm Hosp. 2025 Apr 2:S1130-6343(25)00019-4. doi: 10.1016/j.farma.2025.03.001. Online ahead of print.PMID: 40180861 Free article.English, Spanish.

 

  1. Frequency of Biological Drug Use in Older Patients with Immune-Mediated Inflammatory Diseases: Results from the Large-Scale Italian VALORE Distributed Database Network. Soardo F, Spini A, Pellegrini G, Costa G, Mathieu C, Bellitto C, L'Abbate L, Ingrasciotta Y, Leoni O, Zanforlini M, Ancona D, Stella P, Cavazzana A, Scapin A, Lopes S, Belleudi V, Ledda S, Carta P, Rossi P, Ejlli L, Sapigni E, Puccini A, Scarpelli RF, De Sarro G, Allotta A, Pollina SA, Da Cas R, Bucaneve G, Mangano AMP, Balducci F, Sorrentino C, Senesi I, Tuccori M, Gini R, Spila-Alegiani S, Massari M, Urru SAM, Campomori A, Trifirò G. 2025 Apr 3. doi: 10.1007/s40259-025-00716-2. Online ahead of print.PMID: 40180772

 

  1. Comments on "Dupilumab and neuropsychiatric outcomes in pediatric atopic dermatitis: a real-world cohort analysis". Li R, Zhang J, Wang L, Zhang LY.J Am Acad Dermatol. 2025 Apr 1:S0190-9622(25)00554-7. doi: 10.1016/j.jaad.2025.03.080. Online ahead of print.PMID: 40180128 No abstract available.

 

  1. Programmed cell death 1 inhibitor combined with chemotherapy compared to chemotherapy alone as first-line treatment in advanced gastric cancer patients: A real-world study. Hua Y, Gao Y, Luo S, Song G, Tian X, Wang C, Lv S, Zhang X, Shao G.Int Immunopharmacol. 2025 Apr 2;154:114487. doi: 10.1016/j.intimp.2025.114487. Online ahead of print.PMID: 40179586

 

  1. Risk factors of digital gangrene secondary to systemic lupus erythematosus flare:a real-world data from 2014 to 2022. Liu Y, Li Q, Qiao P, Liu Y, Gao W, Yang Y, Liu S, Xu K.Rheumatology (Oxford). 2025 Apr 3:keaf123. doi: 10.1093/rheumatology/keaf123. Online ahead of print.PMID: 40178987

 

  1. Efficacy and Safety of the PRESERFLO™ MicroShunt in Pediatric Glaucoma. Duarte SR, Lima-Cabrita A, Barão RC, Barata A, Brito C, Stalmans I, Lemmens S, Breda JB, Pinto LA, Teixeira FJ.J Glaucoma. 2025 Apr 4. doi: 10.1097/IJG.0000000000002574. Online ahead of print.PMID: 40178489

 

  1. Adverse Events Associated With Peripheral Nerve Stimulation: An Analysis of the MAUDE Data base and Implications for Pain and Spine Clinicians. Cooper AN, Sen H, Kanjanapanang N, Saad K, Wahl G, Essman M, Fogarty AE, Burnham T, Conger AM, McCormick ZL, Glinka Przybysz A, Young C. 2025 Apr 3:S1094-7159(25)00031-5. doi: 10.1016/j.neurom.2025.02.002. Online ahead of print.PMID: 40178466

 

  1. Renin-angiotensin-aldosterone system inhibitor use improves clinical outcomes in patients with metabolic dysfunction-associated steatotic liver diseases: Target trial emulation using real-world data. Ng WH, Yeo YH, Kim H, Seki E, Rees J, Ma KS, Moylan CA, Rodriquez LM, Abdelmalek M, Villanueva A, Noureddin M, Yang JD. 2025 Apr 2. doi: 10.1097/HEP.0000000000001333. Online ahead of print.PMID: 40178454

 

  1. Respiratory Syncytial Virus Incidence in Young Children in the United States: Impact of Methodologies and Patient Characteristics. Nduaguba SO, Tran PT, Shih R, Finelli L, Choi Y, Wang Y, Winterstein AG.Influenza Other Respir Viruses. 2025 Apr;19(4):e70094. doi: 10.1111/irv.70094.PMID: 40176778 Free PMC article.

 

  1. Global estimation of the bleeding episodes treatable with desmopressin in von Willebrand disease and hemophilia A. Gringeri A, Mannucci PM, Gringeri M, Castaman G, Peyvandi F. 2025 Apr 3. doi: 10.3324/haematol.2025.287572. Online ahead of print.PMID: 40176766 Free article.

 

  1. Clinicopathological Factors That Predict Different Responses of Breast and Axillary Tumors to Neoadjuvant Chemotherapy and Prognosis Among Patients With Node-Positive Breast Cancer: Real World Data. Ji D, Lan B, Wang J, Ma F, Luo Y, Li Q, Zhang P, Cai R, Li Q, Chen S, Xu B, Fan Y.Thorac Cancer. 2025 Apr;16(7):e70035. doi: 10.1111/1759-7714.70035.PMID: 40176396 Free PMC article.

 

  1. Improved Clinical Outcomes With Elexacaftor/Tezacaftor/Ivacaftor in Patients With Cystic Fibrosis and Advanced Lung Disease: Real-World Evidence From an Italian Single-Center Study. Perrotta N, Fiorito LA, Casini G, Gentile R, Vescovo R, Piciocchi A, Lobello R, Cappelli C, Poscia R, Cimino G.Pharmacol Res Perspect. 2025 Apr;13(2):e70083. doi: 10.1002/prp2.70083.PMID: 40176392 Free PMC article.

 

  1. Real-world data of siltuximab for Chinese patients with iMCD: combination with BCD regimen as a potential approach for severe cases. Li SY, Gao YH, Dang Y, Chang L, Shen KN, Cai HC, Zhao DQ, Wei C, Feng J, Zhang L, Li J.Ann Hematol. 2025 Apr 3. doi: 10.1007/s00277-025-06329-7. Online ahead of print.PMID: 40175604

 

  1. Large-Scale Evaluation and Liver Disease Risk Prediction in Finland's National Electronic Health Record System: Feasibility Study Using Real-World Data. Männikkö V, Tommola J, Tikkanen E, Hätinen OP, Åberg F.JMIR Med Inform. 2025 Apr 2;13:e62978. doi: 10.2196/62978.PMID: 40172947 Free article.

 

  1. Evaluating the Real-World Use of Topical Diclofenac Sodium Gel 1% Using US Longitudinal Electronic Health Records Database: A study supporting OTC switch. Sicignano NM, Revel FB, Petruschke R, Barbone FP, Nicholson K, Edison JD.Pain Ther. 2025 Apr 2. doi: 10.1007/s40122-025-00723-9. Online ahead of print.PMID: 40172751

 

  1. Temporal trend in venous thromboembolism hospitalization rates in Brazil. Soares Oliveira Portela F, Wolosker N, Louzada ACS, Portugal MFC, Fiorelli Alexandrino da Silva M, Lopes Cintra D, Girardi GPSSM, Fioranelli A, Teivelis MP.Rev Assoc Med Bras (1992). 2025 Mar 31;71(2):e20240608. doi: 10.1590/1806-9282.20240608. eCollection 2025.PMID: 40172380 Free PMC article.

 

  1. Real-world data analysis of topotecan in combination with Bevacizumab or CycloPhosphamide in the FDA adverse event reporting system (FAERS) database. Chen H, Zhuang G, Hong S, Wu J.Expert Opin Drug Saf. 2025 Apr 2:1-12. doi: 10.1080/14740338.2025.2488240. Online ahead of print.PMID: 40172256

 

  1. Real-world evidence comparing oral anticoagulants for NVAF in Europe: a systematic review and network meta-analysis. Cichewicz A, Jawla S, Zuchinali P, Akin-Fajiye M, Massierer D, Porto I, Garcia-Moll X.Future Cardiol. 2025 Apr 2:1-20. doi: 10.1080/14796678.2025.2484119. Online ahead of print.PMID: 40172192 Review.

 

  1. Glucocorticoid-induced hyperglycaemia in hospitalised adults: A matched cohort study (2013-2023). Golubic R, Mumbole H, Coleman RL, Rea R, Mathur R, Caleyachetty R, Adler AI.Diabetes Obes Metab. 2025 Apr 2. doi: 10.1111/dom.16378. Online ahead of print.PMID: 40171899

 

  1. Sick days glycaemic outcomes in a cohort of children and adolescents with type 1 diabetes using an AID system-A preliminary report. Tinti D, Nobili C, Bettin G, Roggero E, Bondanese A, Trada M, Gerace A, de Sanctis L.Diabetes Obes Metab. 2025 Apr 2. doi: 10.1111/dom.16377. Online ahead of print.PMID: 40171895 No abstract available.

 

  1. New Function for Safety Signal Monitoring in MID-NET®: The Case of an Anti-COVID-19 Drug. Okada Y, Ando T, Takahashi F, Watanabe K, Kajiyama K, Hasegawa T, Inomata S, Kinoshita Y, Watanabe S, Uyama Y.Clin Transl Sci. 2025 Apr;18(4):e70208. doi: 10.1111/cts.70208.PMID: 40171834 Free PMC article.

 

  1. Time-to-event prediction in ALS using a landmark modeling approach, using the ALS Natural History Consortium dataset. Schneck D, Arguedas A, Xenopoulos-Oddsson A, Arcila-Londono X, Lunetta C, Wymer J, Olney N, Gwathmey K, Ajroud-Driss S, Hayat G, Heiman-Patterson T, Cerri F, Fournier C, Glass J, Sherman A, Fiecas M, Walk D.Amyotroph Lateral Scler Frontotemporal Degener. 2025 Apr 2:1-9. doi: 10.1080/21678421.2025.2482943. Online ahead of print.PMID: 40170672

 

  1. Long-Term Glycemic Benefits and User Interaction Insights: Real-World Outcomes of Automated Insulin Delivery Use in a Pediatric Population. Lindkvist EB, Ranjan AG, Nørgaard K, Svensson J.Diabetes Technol Ther. 2025 Apr 2. doi: 10.1089/dia.2025.0068. Online ahead of print.PMID: 40170568

 

  1. Use of Real-World Claims Data to Assess the Prevalence of Concomitant Medications to Inform Drug-Drug Interaction Risk in Target Patient Populations. Tang AS, Brooks L, Boudreau DM, Chanu P, Joshi A, Vora B, Zhu R.Clin Pharmacol Ther. 2025 Apr 1. doi: 10.1002/cpt.3652. Online ahead of print.PMID: 40170515

 

  1. Ultra-Hypofractionated Radiotherapy for Early-Stage Glottic Cancer: Real-World Data From a Single Center. Gundog M, Kiraz E.Head Neck. 2025 Apr 1. doi: 10.1002/hed.28139. Online ahead of print.PMID: 40170367

 

  1. Real-World Impact of Steerable Sheaths for Paroxysmal Atrial Fibrillation Catheter Ablation: The INSIGHT Study. Okumura Y, Kono T, Mizukami A, Inaba O, Wakamatsu Y, Yamagishi D, Nakamura S, Arashiro T, Sato A, Wang Y, Kobori A.J Cardiovasc Electrophysiol. 2025 Apr 1. doi: 10.1111/jce.16658. Online ahead of print.PMID: 40170320

 

  1. A Real-World Evidence Study Evaluating Oral-Health-Related Quality of Life Following the Use of Anti-Sensitivity Toothpaste for Self-Reported Dentine Hypersensitivity Management. Grimaldi R, Baker SR, Shah P, Sanchez E, Shanga G, Gomez-Pereira PR, Parkinson CR.J Clin Periodontol. 2025 Apr 1. doi: 10.1111/jcpe.14155. Online ahead of print.PMID: 40170098

 

  1. Factors associated with increased severity of generalized myasthenia gravis among patients in the United States and Europe. Pesa J, Choudhry Z, de Courcy J, Barlow S, Birija SL, Chatterton E, Gibson G, Hahn B, Govindarajan R.Sci Rep. 2025 Apr 1;15(1):11108. doi: 10.1038/s41598-025-93464-w.PMID: 40169850 Free PMC article.

 

  1. Pancreatic Enzyme Replacement Therapy in Pancreatic Exocrine Insufficiency-Real-World's Dosing and Effectiveness: A Systematic Review. Kadaj-Lipka R, Monica M, Stożek-Tutro A, Ryś P, Rydzewska G.Dig Dis Sci. 2025 Apr 1. doi: 10.1007/s10620-025-09011-0. Online ahead of print.PMID: 40169459 Review.

 

  1. Osteoporosis medication use over time in the United States and Canada. Hayes KN, Zullo AR, Berry SD, Oganisian A, Aggarwal S, Adegboye M, Cadarette SM.Osteoporos Int. 2025 Apr 2. doi: 10.1007/s00198-025-07484-3. Online ahead of print.PMID: 40169456

 

  1. A comparison of breast cancer incidence and cancer stages before and after the introduction of the Austrian national breast cancer screening program in the federal state of Salzburg: Real-world data from the Tumor Registry Salzburg. Gampenrieder SP, Vaisband M, Rinnerthaler G, Weiss L, Jaud B, Sprenger M, Greil R.Wien Klin Wochenschr. 2025 Apr 1. doi: 10.1007/s00508-025-02508-8. Online ahead of print.PMID: 40167619

 

  1. Artificial Intelligence in key pricing, reimbursement and market access (PRMA) processes: better, faster, cheaper - can you really pick two? Dietrich ES.J Med Econ. 2025 Apr 1:1-19. doi: 10.1080/13696998.2025.2488154. Online ahead of print.PMID: 40167461 Free article.

 

  1. Immune checkpoint inhibitors and myocarditis in advanced non-small cell lung cancer: a nationwide cohort study. Li FX, Cai JX, Li JB, Luo KJ, Wang SY, Meng WH, Sha F, Yang ZR, Hackshaw A, Tang JL. 2025 Mar 31;11(1):33. doi: 10.1186/s40959-025-00325-6.PMID: 40165308 Free PMC article.

 

  1. Long-term survival, patterns of progression, and patterns of use for patients with newly diagnosed glioblastoma treated with or without Tumor Treating Fields (TTFields) in a real-world setting. Riegel DC, Bureau BL, Conlon P, Chavez G, Connelly JM.J Neurooncol. 2025 Mar 31. doi: 10.1007/s11060-025-04946-w. Online ahead of print.PMID: 40163248

 

  1. All-cause healthcare resource utilization and costs among community-managed adults with long-COVID in France, 2020-2023. Yang J, Tamberou C, Arnee E, Squara PA, Boukhlal A, Nguyen JL, Volkman HR, Fiévez S, Lepoutre-Bourguet M, Ren J, Ben Romdhane H, Crépey P, Robineau O.J Med Econ. 2025 Mar 31:1-17. doi: 10.1080/13696998.2025.2485626. Online ahead of print.PMID: 40162934 Free article.

 

  1. Loss of response to off-label swallowed topical corticosteroids in eosinophilic esophagitis can be overcome by a switch to an esophageal-targeted budesonide formulation. Murray FR, Rossel JB, Safroneeva E, Saner C, Morell B, Kreienbuehl A, Greuter T, Straumann A, Biedermann L, Schoepfer A, Schreiner P.Am J Gastroenterol. 2025 Mar 31. doi: 10.14309/ajg.0000000000003449. Online ahead of print.PMID: 40162678

 

  1. Real-world evidence to support health technology assessment and payer decision making: is it now or never? Murphy LA, Akehurst R, Cunningham D, de Pouvourville G, Solà-Morales O.Int J Technol Assess Health Care. 2025 Mar 31;41(1):e20. doi: 10.1017/S0266462325000145.PMID: 40162485

 

  1. Economic burden of disease and mortality of intracranial haemorrhage under oral FXai: a German claims data analysis. Huttner HB, Scherg F, Kopke K, Schultze M, Kossack N, Gerner ST, Kuramatsu JB, Schwab S.Neurol Res Pract. 2025 Mar 31;7(1):21. doi: 10.1186/s42466-025-00366-3.PMID: 40159494 Free PMC article.

 

  1. Real-world Data of the Lung Cancer Compact Panel in Non-small Cell Lung Cancer Using Tissue Samples. Taniguchi Y, Tamiya A, Kamiyama Y, Sumitani H, Iwahashi Y, Tsukaguchi A, Sugimoto E, Inagaki Y, Nakao K, Matsuda Y, Takeda M, Kasai T, Okishio K, Shimizu S.Anticancer Res. 2025 Apr;45(4):1607-1615. doi: 10.21873/anticanres.17542.PMID: 40155005

 

  1. Determining health care cost drivers in older Hodgkin lymphoma survivors using interpretable machine learning methods. Siddiqui ZA, Mbous YP, Nduaguba S, LeMasters T, Scott VG, Patel JS, Sambamoorthi U.J Manag Care Spec Pharm. 2025 Apr;31(4):406-420. doi: 10.18553/jmcp.2025.31.4.406.PMID: 40152796 Free PMC article.

 

  1. Patient and public involvement and engagement in real world data and evidence research across the medicines development cycle: a rapid review of peer-reviewed literature and NICE technology appraisals. Dews SA, Oluwatomi A, Inskip A, Agbeleye O, Markham S, Latchford P, Bohm N, Westergaard P, Butfield R, Campbell-Burton A, Meader N, Stoniute A.Curr Med Res Opin. 2025 Mar 31:1-13. doi: 10.1080/03007995.2025.2482668. Online ahead of print.PMID: 40126390

 

  1. A dataset for mapping the Japanese drugs to RxNorm standard concepts. Kimura E, Kawakami Y, Inoue S, Okajima A.Data Brief. 2025 Feb 21;59:111418. doi: 10.1016/j.dib.2025.111418. eCollection 2025 Apr.PMID: 40124300 Free PMC article.

 

  1. INO-CD22: A multicenter, real-world study of inotuzumab ozogamicin safety and effectiveness in adult patients with relapsed/refractory acute lymphoblastic leukemia. Papayannidis C, Petracci E, Zappasodi P, Fracchiolla N, Ciceri F, Sartor C, Roncoroni E, Di Raimondo F, Mattei D, Giannini MB, Lanza F, Gottardi M, Del Principe MI, Borlenghi E, Fumagalli M, Vallisa D, Sica S, Di Renzo N, Fabbiano F, Todisco E, de Fabritiis P, Luppi M, Passamonti F, Corradini P, Petruzziello F, Pane F, Ferrara F, Mambelli G, Volpi R, Frabetti F, Zingaretti C, Marconi G, Martinelli G. 2025 Apr 1;131(7):e35820. doi: 10.1002/cncr.35820.PMID: 40120068 Free PMC article.

 

  1. Twenty-five years of palivizumab: a global historic review of its impact on the burden of respiratory syncytial virus disease in children. Carbonell-Estrany X, Simões EAF, Bont L, Manzoni P, Zar HJ, Greenough A, Ramilo O, Stein R, Law B, Mejias A, Sanchez Luna M, Checchia PA, Krilov L, Lanari M, Dagan R, Fauroux B, Resch B, Heikkinen T, Domachowske JB, Wildenbeest JG, Martinon-Torres F, Thwaites R, Cetinkaya M, Alharbi AS, Rodriguez-Martinez CE, Noyola DE, Kassim A, Kusuda S, Kang JM, Rodgers-Gray B, Platonova A, Jah F, Paes B.Expert Rev Anti Infect Ther. 2025 Apr 1:1-20. doi: 10.1080/14787210.2025.2481908. Online ahead of print.PMID: 40111069 Free article.

 

  1. Advancements in BATTERY longevity of cardiac implantable electronic devices from real-world data: BATTERY study. Kuroda M, Nagashima M, Narita M, Sasaki W, Tanaka N, Matsumoto K, Naganuma T, Mori H, Ikeda Y, Korai K, Fukunaga M, Hiroshima K, Ando K, Kato R.J Arrhythm. 2025 Mar 13;41(2):e70041. doi: 10.1002/joa3.70041. eCollection 2025 Apr.PMID: 40092470 Free PMC article.